Literature DB >> 14553966

Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites.

Jing Cui1, Xiaofeng Zhou, Irmarie Chazaro, Anita L DeStefano, Athanasios J Manolis, Clinton T Baldwin, Haralambos Gavras.   

Abstract

BACKGROUND: Several studies have indicated that a region on human chromosome 17 may influence blood pressure. Our group reported positive linkage for hypertension to the region on human chromosome 17, between D17S1814 and D17S800 in white sibling pairs. In this study, we further investigated this result by examining the phenylethanolamine N-methyltransferase (PNMT) gene, which is located at 17q21 within the region where we found linkage.
METHODS: A case/control association study was conducted to evaluate the relationship between genetic variants of the PNMT gene and risk for essential hypertension. Two single nucleotide polymorphisms (SNPs) in the promoter region of the gene were genotyped, PNMT-148 and PNMT-353, in three ethnic samples: African American (117 hypertensive, 96 normotensive), American white (91 hypertensive, 80 normotensive), and Greek white (99 hypertensive, 90 normotensive), using the homogeneous mass extend reaction (Sequenom) and RFLP for genotyping.
RESULTS: A significant difference in allelic frequency of SNP-353 between hypertensives (38.02%) and normotensives (27.35%) in African Americans (P =.019) was found; however, no significant differences were observed for this SNP for the other ethnic groups. No association was found with SNP PNMT-148 in any of the ethnic groups. Frequencies of haplotypes based on the two SNPs were also compared between hypertensive and normotensive individuals. No significant difference was found in estimated haplotype frequencies between hypertensive and control subjects in the three ethnic groups.
CONCLUSIONS: These results suggest that genetic variants of PNMT may play a role in the development of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553966     DOI: 10.1016/s0895-7061(03)01026-4

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  14 in total

1.  Conserved regulatory motifs at phenylethanolamine N-methyltransferase (PNMT) are disrupted by common functional genetic variation: an integrated computational/experimental approach.

Authors:  Juan L Rodríguez-Flores; Kuixing Zhang; Sun Woo Kang; Gen Wen; Sajalendu Ghosh; Ryan S Friese; Sushil K Mahata; Shankar Subramaniam; Bruce A Hamilton; Daniel T O'Connor
Journal:  Mamm Genome       Date:  2010-03-05       Impact factor: 2.957

2.  Beta-2 adrenergic receptor polymorphisms and the forearm blood flow response to mental stress.

Authors:  Zhong Liu; Sunni A Barnes; Lynn A Sokolnicki; Eric M Snyder; Bruce D Johnson; Stephen T Turner; Michael J Joyner; John H Eisenach
Journal:  Clin Auton Res       Date:  2006-04       Impact factor: 4.435

3.  Polymorphisms and disease: hotspots of inactivation in methyltransferases.

Authors:  Karen Rutherford; Valerie Daggett
Journal:  Trends Biochem Sci       Date:  2010-04-09       Impact factor: 13.807

4.  Genetic regulation of catecholamine synthesis, storage and secretion in the spontaneously hypertensive rat.

Authors:  M L Jirout; R S Friese; N R Mahapatra; M Mahata; L Taupenot; S K Mahata; V Kren; V Zídek; J Fischer; H Maatz; M G Ziegler; M Pravenec; N Hubner; T J Aitman; N J Schork; D T O'Connor
Journal:  Hum Mol Genet       Date:  2010-04-08       Impact factor: 6.150

5.  Systematic polymorphism discovery after genome-wide identification of potential susceptibility loci in a hereditary rodent model of human hypertension.

Authors:  Ryan S Friese; Geert W Schmid-Schönbein; Daniel T O'Connor
Journal:  Blood Press       Date:  2011-03-23       Impact factor: 2.835

Review 6.  Past, present and future of human chromaffin cells: role in physiology and therapeutics.

Authors:  Alberto Pérez-Alvarez; Alicia Hernández-Vivanco; Almudena Albillos
Journal:  Cell Mol Neurobiol       Date:  2010-11-24       Impact factor: 5.046

7.  Catecholamine pathway gene variation is associated with norepinephrine and epinephrine concentrations at rest and after exercise.

Authors:  Laxmi V Ghimire; Utkarsh Kohli; Chun Li; Gbenga G Sofowora; Mordechai Muszkat; Eitan A Friedman; Joseph F Solus; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Pharmacogenet Genomics       Date:  2012-04       Impact factor: 2.089

8.  Intestinal Gastrin/CCKBR (Cholecystokinin B Receptor) Ameliorates Salt-Sensitive Hypertension by Inhibiting Intestinal Na+/H+ Exchanger 3 Activity Through a PKC (Protein Kinase C)-Mediated NHERF1 and NHERF2 Pathway.

Authors:  Xiaoliang Jiang; Yunpeng Liu; Xin-Yang Zhang; Xue Liu; Xing Liu; Xianxian Wu; Pedro A Jose; Shun Duan; Fu-Jian Xu; Zhiwei Yang
Journal:  Hypertension       Date:  2022-06-08       Impact factor: 9.897

9.  Salt-sensitive hypertension and cardiac hypertrophy in transgenic mice expressing a corin variant identified in blacks.

Authors:  Wei Wang; Yujie Cui; Jianzhong Shen; Jingjing Jiang; Shenghan Chen; Jianhao Peng; Qingyu Wu
Journal:  Hypertension       Date:  2012-09-17       Impact factor: 10.190

10.  Phenylethanolamine N-methyltransferase gene polymorphisms associate with crisis pain in sickle cell disease patients.

Authors:  Nilanjana Sadhu; Ellie H Jhun; Andrew Posen; Yingwei Yao; Ying He; Robert E Molokie; Diana J Wilkie; Zaijie J Wang
Journal:  Pharmacogenomics       Date:  2020-03-12       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.